059210.KQ Meta Biomed Co. Ltd

Healthcare Health Care Equipment & Supplies KOSDAQ
4,091 KRW
Close of Oct 30, 2026
3,251 6,217
Market cap
KRW 96.1B
P/E
-
P/B
0.74x
ROE
16.7%
Dividend yield
0.71%
Fundamental score
3.2/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 059210.KQ undervalued?

Graham number

The Graham number of Meta Biomed Co. Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Meta Biomed Co. Ltd fundamental analysis

14 of 22 checks passed

ROE 1/2

Moderate return on equity (16.7%), between 10% and 20%.

ROA 1/1

Return on assets (11.2%) is above the industry median (6.2%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-58.2%) is below the industry median (0.5%).

Revenue Growth 2/2

Revenue grew 14.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (4.4%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 15.5x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (0.7x) is above the industry median (0.7x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (0.7%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 2/2

Dividends paid without a cut of more than 10% for 11 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 6.2%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Meta Biomed Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Meta Biomed Co. Ltd

Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone products consisting of bone graft substitutes and cement; and cosmetic medical products…

Full company profile